Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zimu Wang

Showing results (21-30 of 41) with videos related to

Pageof 5
Sort By:
Angewandte Chemie (International Ed. in English)|September 6, 2017
Combining Orthogonal Chain-End Deprotections and Thiol-Maleimide Michael Coupling: Engineering Discrete Oligomers by an Iterative Growth StrategyZhihao Huang, Junfei Zhao, Zimu Wang, et al.
International Immunopharmacology|June 20, 2024
A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancerXueying Zuo, Qinpei Cheng, Zimu Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Targeting Methylglyoxal Metabolism to Enhance Ferroptosis Sensitivity in Tumor TherapyXinyue Zhang, Leng Han, Zimu Wang, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2023
Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fractionZhonglei Xie, Baozhen Qi, Zimu Wang, et al.
Autophagy|May 25, 2026
Mammalian Lysophagy: mechanisms and pathophysiological implicationsFujian Ji, Mingran Dai, Zimu Wang, et al.
Frontiers in Oncology|April 8, 2021
Association of <i>MUC19</i> Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung CancerLi Zhou, Litang Huang, Qiuli Xu, et al.
Mediators of Inflammation|June 26, 2025
WTAP Accelerates Exhaustion of CD8<sup>+</sup> T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNARong Li, Shunle Li, Hua Li, et al.
Theranostics|September 30, 2024
Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fractionShuai Yuan, Zimu Wang, Shun Yao, et al.
Cancer Cell International|August 15, 2021
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancerXinying Li, Cen Chen, Zimu Wang, et al.
Theranostics|August 4, 2025
Harnessing mRNA for heart health: a new era in cardiovascular treatmentFengli Peng, Zhimei Qiu, Zimu Wang, et al.
Pageof 5

Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Angewandte Chemie (International Ed. in English)|September 6, 2017
Combining Orthogonal Chain-End Deprotections and Thiol-Maleimide Michael Coupling: Engineering Discrete Oligomers by an Iterative Growth StrategyZhihao Huang, Junfei Zhao, Zimu Wang, et al.
International Immunopharmacology|June 20, 2024
A novel oral TLR7 agonist orchestrates immune response and synergizes with PD-L1 blockade via type I IFN pathway in lung cancerXueying Zuo, Qinpei Cheng, Zimu Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 5, 2025
Targeting Methylglyoxal Metabolism to Enhance Ferroptosis Sensitivity in Tumor TherapyXinyue Zhang, Leng Han, Zimu Wang, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2023
Ablation for atrial fibrillation improves the outcomes in patients with heart failure with preserved ejection fractionZhonglei Xie, Baozhen Qi, Zimu Wang, et al.
Autophagy|May 25, 2026
Mammalian Lysophagy: mechanisms and pathophysiological implicationsFujian Ji, Mingran Dai, Zimu Wang, et al.
Frontiers in Oncology|April 8, 2021
Association of <i>MUC19</i> Mutation With Clinical Benefits of Anti-PD-1 Inhibitors in Non-small Cell Lung CancerLi Zhou, Litang Huang, Qiuli Xu, et al.
Mediators of Inflammation|June 26, 2025
WTAP Accelerates Exhaustion of CD8<sup>+</sup> T Cells and Progression of Hepatocellular Carcinoma by Promoting m6A Modification and Translation of PD1 mRNARong Li, Shunle Li, Hua Li, et al.
Theranostics|September 30, 2024
Knocking out USP7 attenuates cardiac fibrosis and endothelial-to-mesenchymal transition by destabilizing SMAD3 in mice with heart failure with preserved ejection fractionShuai Yuan, Zimu Wang, Shun Yao, et al.
Cancer Cell International|August 15, 2021
Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancerXinying Li, Cen Chen, Zimu Wang, et al.
Theranostics|August 4, 2025
Harnessing mRNA for heart health: a new era in cardiovascular treatmentFengli Peng, Zhimei Qiu, Zimu Wang, et al.
Pageof 5